ATRA
Atara Biotherapeutics Inc
NASDAQ: ATRA · HEALTHCARE · BIOTECHNOLOGY
$4.77
+3.70% today
Updated 2026-04-30
Market cap
$40.97M
P/E ratio
1.95
P/S ratio
0.34x
EPS (TTM)
$2.57
Dividend yield
—
52W range
$4 – $19
Volume
0.3M
Atara Biotherapeutics Inc (ATRA) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $3.55M | $20.34M | $63.57M | $8.57M | $128.94M | $120.77M |
| Revenue growth (YoY) | — | — | — | — | — | — | — | — | — | +472.6% | +212.6% | -86.5% | +1404.0% | -6.3% |
| Cost of revenue | — | — | $0.00 | $48000.00 | $383000.00 | $956000.00 | $3.78M | $8.11M | $9.87M | $11.38M | $14.57M | $8.89M | $21.01M | $21.21M |
| Gross profit | — | — | $0.00 | $-48000.00 | $-383000.00 | $-956000.00 | $-3.78M | $-8.11M | $-9.87M | $20.34M | $63.57M | $-313000.00 | $107.93M | $99.56M |
| Gross margin | — | — | — | — | — | — | — | — | -277.8% | 100.0% | 100.0% | -3.7% | 83.7% | 82.4% |
| R&D | $9.78M | $4.86M | $15.45M | $41.62M | $56.51M | $81.21M | $167.46M | $216.10M | $244.65M | $282.00M | $272.53M | $224.78M | $151.48M | $37.45M |
| SG&A | $2.50M | $3.76M | $12.71M | $16.83M | $24.73M | $40.33M | $69.65M | $79.58M | $64.40M | $78.80M | $71.55M | $50.91M | $39.89M | $26.25M |
| Operating income | $-3.23M | $-8.62M | $-28.16M | $-58.45M | $-81.24M | $-121.53M | $-237.11M | $-295.68M | $-309.05M | $-340.46M | $-280.51M | $-276.01M | $-83.44M | $35.86M |
| Operating margin | — | — | — | — | — | — | — | — | -8700.8% | -1673.9% | -441.2% | -3219.5% | -64.7% | 29.7% |
| EBITDA | $-4.09M | $-8.61M | $-28.15M | $-58.40M | $-80.86M | $-120.58M | $-233.38M | $-288.61M | $-300.72M | $-331.12M | $-222.26M | $-266.00M | $-75.75M | $50.41M |
| EBITDA margin | — | — | — | — | — | — | — | — | -8466.2% | -1627.9% | -349.6% | -3102.7% | -58.7% | 41.7% |
| EBIT | $-7.32M | $-8.62M | $-28.16M | $-58.45M | $-81.24M | $-121.53M | $-237.11M | $-295.68M | $-309.05M | $-340.46M | $-227.92M | $-270.83M | $-80.80M | $49.77M |
| Interest expense | — | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $11.79M | $10.78M | $9.71M | $373000.00 | $5.29M | $4.62M | $3.79M |
| Income tax | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-123.30M | $-87.73M | $-28.01M | $-57.22M | $-79.05M | $-119.49M | $-230.70M | $-290.98M | $-306.62M | $-340.14M | $-228.30M | $-276.13M | $-85.40M | $32.69M |
| Net income growth (YoY) | — | +28.8% | +68.1% | -104.3% | -38.1% | -51.2% | -93.1% | -26.1% | -5.4% | -10.9% | +32.9% | -20.9% | +69.1% | +138.3% |
| Profit margin | — | — | — | — | — | — | — | — | -8632.3% | -1672.3% | -359.1% | -3220.9% | -66.2% | 27.1% |